Multimodal approaches, including nutritional support, physical therapy, and medications such as ibuprofen (Menac trial) and selective androgen receptor modulators, as well as ghrelin receptor activation with agonists, are recognized as foundational in managing sarcopenia. Here, GHSR is linked to sarcopenia.